THOMAS H. GLOCER - 30 Jun 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Director
Signature
/s/ Jon Filderman as Attorney-in-Fact for Thomas H. Glocer
Issuer symbol
MRK
Transactions as of
30 Jun 2023
Net transactions value
+$45,000
Form type
4
Filing time
05 Jul 2023, 16:36:51 UTC
Previous filing
02 Jun 2023
Next filing
03 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 5,100 30 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Phantom Stock Award $45,000 +390 +0.43% $115.39 90,340 30 Jun 2023 Common Stock 390 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.